Clinical trials for Non-Hodgkin lymphoma

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Non-Hodgkin lymphoma. For all clinical trials, go to clinical trials search

This list shows clinical trials for Non-Hodgkin lymphoma

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Non-Hodgkin lymphoma
Title Recruitment status Location
Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma Recruiting United Kingdom
An evaluation of therapy for B-cell lymphoma with Bortezomib Recruiting United Kingdom
Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing Regimen Recruiting United Kingdom
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Recruiting United Kingdom
ENRICH Ibrutinib for untreated mantle cell lymphoma Recruiting United Kingdom
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Recruiting United Kingdom
Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma Recruiting United Kingdom
A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma Recruiting United Kingdom
Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation Recruiting United Kingdom
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients Recruiting United Kingdom

Page last reviewed: 22/03/2012

Next review due: 22/03/2014